Výsledky vyhledávání - "Maria Petrecz"

Akademický článek

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines

Autor: Maria Petrecz, Camilo J. Acosta, Stephanie O. Klopfer, Barbara J. Kuter, Michelle G. Goveia, Jon E. Stek, Florian P. Schödel, Andrew W. Lee

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 426-432 (2019)

Safety and immunogenicity data from 5 clinical trials conducted in the US in children 12-to-23 months old where HAVi was administered alone or concomitantly with other pediatric vaccines (M-M-R®II, Varivax®, TRIPEDIA®, Prevnar®, ProQuad®, Pedvax

Externí odkaz: https://doaj.org/article/4b3c986dcd8c4a55896ab3ff7c781e21

Zobrazit plný text záznamu

Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA™)

Autor: Jon E. Stek, Jakub K. Simon, Jason C. Martin, Michelle G. Goveia, Stephanie O. Klopfer, Maria Petrecz

Publikováno v: Vaccine. 39(20)

VAQTA™ (Hepatitis A Vaccine, inactivated [HAVi]; Merck & Co., Inc., Kenilworth, NJ, USA) is currently licensed for prevention of disease caused by hepatitis A virus in persons ≥12 months of age. This report summarizes statistical models developed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6326539e9f2dece20740f2e0cb3e81d8
https://pubmed.ncbi.nlm.nih.gov/33867215

Zobrazit plný text záznamu

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines

Autor: Michelle G. Goveia, Camilo J. Acosta, Stephanie O. Klopfer, Florian Schödel, Jon E. Stek, Barbara J. Kuter, Andrew W. Lee, Maria Petrecz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605c30d140757a1512e52e69ed7d0d2d
https://europepmc.org/articles/PMC6422454/

Zobrazit plný text záznamu

Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children

Autor: Maria Petrecz, Jon E. Stek, Barbara J. Kuter, Anton Duke, Florian Schödel, Julie Shepard, Andrew W. Lee, Stephanie O. Klopfer, Robert J. Yetman

Publikováno v: Human Vaccines & Immunotherapeutics. 9:1691-1697

This open-label, multicenter, randomized, comparative study evaluated immunogenicity, safety and tolerability of concomitant (Group 1; n = 330) vs. non-concomitant (Group 2; n = 323) VAQTA™ (25U/0.5 mL) (hepatitis A vaccine; HAV) with ProQuad™ (m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466a8c5e7be02f10eed6a3a4f79c5af6
https://doi.org/10.4161/hv.24873

Zobrazit plný text záznamu

SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

Autor: Maria Petrecz, Susan K. Bradshaw, Kim M. Strohmaier, Theoklis E. Zaoutis, Michael R. Bourque, Arlene Taylor, Johan Maertens, Angela L. Ngai, Andreas H. Groll, Nicholas A. Kartsonis, William J. Steinbach, Thomas Lehrnbecher, Hasan S. Jafri, Joseph W. Chow

Publikováno v: Pediatric Infectious Disease Journal. 28:1132-1135

We analyzed the caspofungin safety experience in 5 clinical registration studies in 171 pediatric patients, 1 week to 17 years of age. Caspofungin was administered for 1 to 87 (mean 12.1) days. The most common drug-related adverse events were fever,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95bf271284f10ca2001d0307ed542094
https://doi.org/10.1097/inf.0b013e3181af5a15

Zobrazit plný text záznamu

Concomitant Use of the 3-Dose Oral Pentavalent Rotavirus Vaccine With a 3-Dose Primary Vaccination Course of a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine

Autor: Guanghan F. Liu, Thomas Rose, Florian Schödel, Su He, Maria Petrecz, Max Ciarlet, Sherry Lai, Dieter Y. Koller, Pierre Van Damme, Falko Panzer, Penny M. Heaton, Elena Mikviman, Guojun Yuan

Publikováno v: The pediatric infectious disease journal

Background: The pentavalent rotavirus vaccine (PRV), RotaTeq, can be concomitantly administered with most routine childhood vaccines. This study evaluated the immunogenicity and reactogenicity of PRV when used concomitantly with a hexavalent vaccine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6304fd847cf5db6caacf334f3976c451
https://doi.org/10.1097/inf.0b013e31818c0161

Zobrazit plný text záznamu

Concomitant use of VAQTA with PedvaxHIB and Infanrix in 12 to 17 month old children

Autor: Keith P Ramsey, Jon E. Stek, Florian Schödel, Barbara J. Kuter, Andrew W. Lee, Maria Petrecz, Jason C. Martin, Stephanie O. Klopfer

Publikováno v: Human vaccinesimmunotherapeutics. 12(2)

Open-label, multicenter, randomized study (NCT00289913) evaluated immunogenicity, safety, and tolerability of Vaqta® (hepatitis A vaccine) administered with PedvaxHIB® (Haemophilus b conjugate vaccine [Meningococcal protein conjugate]) & Infanrix®

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09d1c6b01f2921711c99ca9758bccce
https://pubmed.ncbi.nlm.nih.gov/26308112

Zobrazit plný text záznamu

Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants

Autor: Angela L Ngai, Gregory L Adams, Guanghan Liu, Ginamarie Foglia, Michael Leonardi, Jon E. Stek, Gary S. Marshall, Maria Petrecz, Andrew W. Lee, Sheryl Flores, Jin Xu

Publikováno v: Pediatrics. 136(2)

BACKGROUND: DTaP5-IPV-Hib-HepB is a fully liquid investigational hexavalent vaccine directed against 6 diseases. METHODS: This multicenter, open-label, comparator-controlled, phase III study randomly assigned healthy infants 2-to-1 as follows: group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad44c1b92decee8b5cd3e13ef5abf16
https://pubmed.ncbi.nlm.nih.gov/26216331

Zobrazit plný text záznamu

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)

Autor: Anthony D. Grosso, Jon E. Stek, Barbara J. Kuter, Julie L. Gardner, Steven Black, Stephanie O. Klopfer, Maria Petrecz, Keith S. Reisinger, Florian Schödel, Ouzama Nicholson, Michelle G. Goveia, Michelle L Brown

Publikováno v: Vaccine. 32(52)

Background In randomized clinical studies, over 11,800 children, 12 months to 6 years of age, were administered ProQuad ® , a combination measles, mumps, rubella, and varicella vaccine (MMRV). This paper describes the safety following a 2-dose regim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b82dbca9914d8bb2e305603186e57e
https://pubmed.ncbi.nlm.nih.gov/25219563

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání